According to our latest study, the global Chronic Pain Topical Analgesics market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Chronic Pain Topical Analgesics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Chronic Pain Topical Analgesics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Chronic Pain Topical Analgesics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Chronic Pain Topical Analgesics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Chronic Pain Topical Analgesics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chronic Pain Topical Analgesics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chronic Pain Topical Analgesics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche (Genentech), Amgen, B-MS, Merck and Pfizer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Chronic Pain Topical Analgesics market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Analgesic Creams
Analgesic Sprays
Pain Relief Patches
Market segment by Application
Muscle Pain
Arthritis Pain
Market segment by players, this report covers
Roche (Genentech)
Amgen
B-MS
Merck
Pfizer
Novartis
Eli Lilly and Company
Johnson & Johnson
GSK
Sanofi
Boehringer Ingelheim
Zhejiang Jiuzhou Pharmaceutical
Hisamitsu
Mylan
Lingrui
Teikoku Seiyaku
The Pure Source
Mercury Healthcare
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Chronic Pain Topical Analgesics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Chronic Pain Topical Analgesics, with revenue, gross margin and global market share of Chronic Pain Topical Analgesics from 2018 to 2023.
Chapter 3, the Chronic Pain Topical Analgesics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Chronic Pain Topical Analgesics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Chronic Pain Topical Analgesics.
Chapter 13, to describe Chronic Pain Topical Analgesics research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Chronic Pain Topical Analgesics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Chronic Pain Topical Analgesics by Type
1.3.1 Overview: Global Chronic Pain Topical Analgesics Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Chronic Pain Topical Analgesics Consumption Value Market Share by Type in 2022
1.3.3 Analgesic Creams
1.3.4 Analgesic Sprays
1.3.5 Pain Relief Patches
1.4 Global Chronic Pain Topical Analgesics Market by Application
1.4.1 Overview: Global Chronic Pain Topical Analgesics Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Muscle Pain
1.4.3 Arthritis Pain
1.5 Global Chronic Pain Topical Analgesics Market Size & Forecast
1.6 Global Chronic Pain Topical Analgesics Market Size and Forecast by Region
1.6.1 Global Chronic Pain Topical Analgesics Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Chronic Pain Topical Analgesics Market Size by Region, (2018-2029)
1.6.3 North America Chronic Pain Topical Analgesics Market Size and Prospect (2018-2029)
1.6.4 Europe Chronic Pain Topical Analgesics Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Chronic Pain Topical Analgesics Market Size and Prospect (2018-2029)
1.6.6 South America Chronic Pain Topical Analgesics Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Chronic Pain Topical Analgesics Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Roche (Genentech)
2.1.1 Roche (Genentech) Details
2.1.2 Roche (Genentech) Major Business
2.1.3 Roche (Genentech) Chronic Pain Topical Analgesics Product and Solutions
2.1.4 Roche (Genentech) Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche (Genentech) Recent Developments and Future Plans
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Chronic Pain Topical Analgesics Product and Solutions
2.2.4 Amgen Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Amgen Recent Developments and Future Plans
2.3 B-MS
2.3.1 B-MS Details
2.3.2 B-MS Major Business
2.3.3 B-MS Chronic Pain Topical Analgesics Product and Solutions
2.3.4 B-MS Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 B-MS Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Chronic Pain Topical Analgesics Product and Solutions
2.4.4 Merck Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Chronic Pain Topical Analgesics Product and Solutions
2.5.4 Pfizer Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Chronic Pain Topical Analgesics Product and Solutions
2.6.4 Novartis Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Novartis Recent Developments and Future Plans
2.7 Eli Lilly and Company
2.7.1 Eli Lilly and Company Details
2.7.2 Eli Lilly and Company Major Business
2.7.3 Eli Lilly and Company Chronic Pain Topical Analgesics Product and Solutions
2.7.4 Eli Lilly and Company Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Eli Lilly and Company Recent Developments and Future Plans
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business
2.8.3 Johnson & Johnson Chronic Pain Topical Analgesics Product and Solutions
2.8.4 Johnson & Johnson Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Johnson & Johnson Recent Developments and Future Plans
2.9 GSK
2.9.1 GSK Details
2.9.2 GSK Major Business
2.9.3 GSK Chronic Pain Topical Analgesics Product and Solutions
2.9.4 GSK Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 GSK Recent Developments and Future Plans
2.10 Sanofi
2.10.1 Sanofi Details
2.10.2 Sanofi Major Business
2.10.3 Sanofi Chronic Pain Topical Analgesics Product and Solutions
2.10.4 Sanofi Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Sanofi Recent Developments and Future Plans
2.11 Boehringer Ingelheim
2.11.1 Boehringer Ingelheim Details
2.11.2 Boehringer Ingelheim Major Business
2.11.3 Boehringer Ingelheim Chronic Pain Topical Analgesics Product and Solutions
2.11.4 Boehringer Ingelheim Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Boehringer Ingelheim Recent Developments and Future Plans
2.12 Zhejiang Jiuzhou Pharmaceutical
2.12.1 Zhejiang Jiuzhou Pharmaceutical Details
2.12.2 Zhejiang Jiuzhou Pharmaceutical Major Business
2.12.3 Zhejiang Jiuzhou Pharmaceutical Chronic Pain Topical Analgesics Product and Solutions
2.12.4 Zhejiang Jiuzhou Pharmaceutical Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments and Future Plans
2.13 Hisamitsu
2.13.1 Hisamitsu Details
2.13.2 Hisamitsu Major Business
2.13.3 Hisamitsu Chronic Pain Topical Analgesics Product and Solutions
2.13.4 Hisamitsu Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Hisamitsu Recent Developments and Future Plans
2.14 Mylan
2.14.1 Mylan Details
2.14.2 Mylan Major Business
2.14.3 Mylan Chronic Pain Topical Analgesics Product and Solutions
2.14.4 Mylan Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Mylan Recent Developments and Future Plans
2.15 Lingrui
2.15.1 Lingrui Details
2.15.2 Lingrui Major Business
2.15.3 Lingrui Chronic Pain Topical Analgesics Product and Solutions
2.15.4 Lingrui Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Lingrui Recent Developments and Future Plans
2.16 Teikoku Seiyaku
2.16.1 Teikoku Seiyaku Details
2.16.2 Teikoku Seiyaku Major Business
2.16.3 Teikoku Seiyaku Chronic Pain Topical Analgesics Product and Solutions
2.16.4 Teikoku Seiyaku Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Teikoku Seiyaku Recent Developments and Future Plans
2.17 The Pure Source
2.17.1 The Pure Source Details
2.17.2 The Pure Source Major Business
2.17.3 The Pure Source Chronic Pain Topical Analgesics Product and Solutions
2.17.4 The Pure Source Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 The Pure Source Recent Developments and Future Plans
2.18 Mercury Healthcare
2.18.1 Mercury Healthcare Details
2.18.2 Mercury Healthcare Major Business
2.18.3 Mercury Healthcare Chronic Pain Topical Analgesics Product and Solutions
2.18.4 Mercury Healthcare Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Mercury Healthcare Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Chronic Pain Topical Analgesics Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Chronic Pain Topical Analgesics by Company Revenue
3.2.2 Top 3 Chronic Pain Topical Analgesics Players Market Share in 2022
3.2.3 Top 6 Chronic Pain Topical Analgesics Players Market Share in 2022
3.3 Chronic Pain Topical Analgesics Market: Overall Company Footprint Analysis
3.3.1 Chronic Pain Topical Analgesics Market: Region Footprint
3.3.2 Chronic Pain Topical Analgesics Market: Company Product Type Footprint
3.3.3 Chronic Pain Topical Analgesics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Chronic Pain Topical Analgesics Consumption Value and Market Share by Type (2018-2023)
4.2 Global Chronic Pain Topical Analgesics Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Chronic Pain Topical Analgesics Consumption Value Market Share by Application (2018-2023)
5.2 Global Chronic Pain Topical Analgesics Market Forecast by Application (2024-2029)
6 North America
6.1 North America Chronic Pain Topical Analgesics Consumption Value by Type (2018-2029)
6.2 North America Chronic Pain Topical Analgesics Consumption Value by Application (2018-2029)
6.3 North America Chronic Pain Topical Analgesics Market Size by Country
6.3.1 North America Chronic Pain Topical Analgesics Consumption Value by Country (2018-2029)
6.3.2 United States Chronic Pain Topical Analgesics Market Size and Forecast (2018-2029)
6.3.3 Canada Chronic Pain Topical Analgesics Market Size and Forecast (2018-2029)
6.3.4 Mexico Chronic Pain Topical Analgesics Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Chronic Pain Topical Analgesics Consumption Value by Type (2018-2029)
7.2 Europe Chronic Pain Topical Analgesics Consumption Value by Application (2018-2029)
7.3 Europe Chronic Pain Topical Analgesics Market Size by Country
7.3.1 Europe Chronic Pain Topical Analgesics Consumption Value by Country (2018-2029)
7.3.2 Germany Chronic Pain Topical Analgesics Market Size and Forecast (2018-2029)
7.3.3 France Chronic Pain Topical Analgesics Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Chronic Pain Topical Analgesics Market Size and Forecast (2018-2029)
7.3.5 Russia Chronic Pain Topical Analgesics Market Size and Forecast (2018-2029)
7.3.6 Italy Chronic Pain Topical Analgesics Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Chronic Pain Topical Analgesics Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Chronic Pain Topical Analgesics Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Chronic Pain Topical Analgesics Market Size by Region
8.3.1 Asia-Pacific Chronic Pain Topical Analgesics Consumption Value by Region (2018-2029)
8.3.2 China Chronic Pain Topical Analgesics Market Size and Forecast (2018-2029)
8.3.3 Japan Chronic Pain Topical Analgesics Market Size and Forecast (2018-2029)
8.3.4 South Korea Chronic Pain Topical Analgesics Market Size and Forecast (2018-2029)
8.3.5 India Chronic Pain Topical Analgesics Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Chronic Pain Topical Analgesics Market Size and Forecast (2018-2029)
8.3.7 Australia Chronic Pain Topical Analgesics Market Size and Forecast (2018-2029)
9 South America
9.1 South America Chronic Pain Topical Analgesics Consumption Value by Type (2018-2029)
9.2 South America Chronic Pain Topical Analgesics Consumption Value by Application (2018-2029)
9.3 South America Chronic Pain Topical Analgesics Market Size by Country
9.3.1 South America Chronic Pain Topical Analgesics Consumption Value by Country (2018-2029)
9.3.2 Brazil Chronic Pain Topical Analgesics Market Size and Forecast (2018-2029)
9.3.3 Argentina Chronic Pain Topical Analgesics Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Chronic Pain Topical Analgesics Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Chronic Pain Topical Analgesics Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Chronic Pain Topical Analgesics Market Size by Country
10.3.1 Middle East & Africa Chronic Pain Topical Analgesics Consumption Value by Country (2018-2029)
10.3.2 Turkey Chronic Pain Topical Analgesics Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Chronic Pain Topical Analgesics Market Size and Forecast (2018-2029)
10.3.4 UAE Chronic Pain Topical Analgesics Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Chronic Pain Topical Analgesics Market Drivers
11.2 Chronic Pain Topical Analgesics Market Restraints
11.3 Chronic Pain Topical Analgesics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Chronic Pain Topical Analgesics Industry Chain
12.2 Chronic Pain Topical Analgesics Upstream Analysis
12.3 Chronic Pain Topical Analgesics Midstream Analysis
12.4 Chronic Pain Topical Analgesics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Chronic Pain Topical Analgesics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Chronic Pain Topical Analgesics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Chronic Pain Topical Analgesics Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Chronic Pain Topical Analgesics Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Roche (Genentech) Company Information, Head Office, and Major Competitors
Table 6. Roche (Genentech) Major Business
Table 7. Roche (Genentech) Chronic Pain Topical Analgesics Product and Solutions
Table 8. Roche (Genentech) Chronic Pain Topical Analgesics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Roche (Genentech) Recent Developments and Future Plans
Table 10. Amgen Company Information, Head Office, and Major Competitors
Table 11. Amgen Major Business
Table 12. Amgen Chronic Pain Topical Analgesics Product and Solutions
Table 13. Amgen Chronic Pain Topical Analgesics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Amgen Recent Developments and Future Plans
Table 15. B-MS Company Information, Head Office, and Major Competitors
Table 16. B-MS Major Business
Table 17. B-MS Chronic Pain Topical Analgesics Product and Solutions
Table 18. B-MS Chronic Pain Topical Analgesics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. B-MS Recent Developments and Future Plans
Table 20. Merck Company Information, Head Office, and Major Competitors
Table 21. Merck Major Business
Table 22. Merck Chronic Pain Topical Analgesics Product and Solutions
Table 23. Merck Chronic Pain Topical Analgesics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Merck Recent Developments and Future Plans
Table 25. Pfizer Company Information, Head Office, and Major Competitors
Table 26. Pfizer Major Business
Table 27. Pfizer Chronic Pain Topical Analgesics Product and Solutions
Table 28. Pfizer Chronic Pain Topical Analgesics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Pfizer Recent Developments and Future Plans
Table 30. Novartis Company Information, Head Office, and Major Competitors
Table 31. Novartis Major Business
Table 32. Novartis Chronic Pain Topical Analgesics Product and Solutions
Table 33. Novartis Chronic Pain Topical Analgesics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Novartis Recent Developments and Future Plans
Table 35. Eli Lilly and Company Company Information, Head Office, and Major Competitors
Table 36. Eli Lilly and Company Major Business
Table 37. Eli Lilly and Company Chronic Pain Topical Analgesics Product and Solutions
Table 38. Eli Lilly and Company Chronic Pain Topical Analgesics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Eli Lilly and Company Recent Developments and Future Plans
Table 40. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 41. Johnson & Johnson Major Business
Table 42. Johnson & Johnson Chronic Pain Topical Analgesics Product and Solutions
Table 43. Johnson & Johnson Chronic Pain Topical Analgesics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Johnson & Johnson Recent Developments and Future Plans
Table 45. GSK Company Information, Head Office, and Major Competitors
Table 46. GSK Major Business
Table 47. GSK Chronic Pain Topical Analgesics Product and Solutions
Table 48. GSK Chronic Pain Topical Analgesics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. GSK Recent Developments and Future Plans
Table 50. Sanofi Company Information, Head Office, and Major Competitors
Table 51. Sanofi Major Business
Table 52. Sanofi Chronic Pain Topical Analgesics Product and Solutions
Table 53. Sanofi Chronic Pain Topical Analgesics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Sanofi Recent Developments and Future Plans
Table 55. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 56. Boehringer Ingelheim Major Business
Table 57. Boehringer Ingelheim Chronic Pain Topical Analgesics Product and Solutions
Table 58. Boehringer Ingelheim Chronic Pain Topical Analgesics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Boehringer Ingelheim Recent Developments and Future Plans
Table 60. Zhejiang Jiuzhou Pharmaceutical Company Information, Head Office, and Major Competitors
Table 61. Zhejiang Jiuzhou Pharmaceutical Major Business
Table 62. Zhejiang Jiuzhou Pharmaceutical Chronic Pain Topical Analgesics Product and Solutions
Table 63. Zhejiang Jiuzhou Pharmaceutical Chronic Pain Topical Analgesics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Zhejiang Jiuzhou Pharmaceutical Recent Developments and Future Plans
Table 65. Hisamitsu Company Information, Head Office, and Major Competitors
Table 66. Hisamitsu Major Business
Table 67. Hisamitsu Chronic Pain Topical Analgesics Product and Solutions
Table 68. Hisamitsu Chronic Pain Topical Analgesics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Hisamitsu Recent Developments and Future Plans
Table 70. Mylan Company Information, Head Office, and Major Competitors
Table 71. Mylan Major Business
Table 72. Mylan Chronic Pain Topical Analgesics Product and Solutions
Table 73. Mylan Chronic Pain Topical Analgesics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Mylan Recent Developments and Future Plans
Table 75. Lingrui Company Information, Head Office, and Major Competitors
Table 76. Lingrui Major Business
Table 77. Lingrui Chronic Pain Topical Analgesics Product and Solutions
Table 78. Lingrui Chronic Pain Topical Analgesics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Lingrui Recent Developments and Future Plans
Table 80. Teikoku Seiyaku Company Information, Head Office, and Major Competitors
Table 81. Teikoku Seiyaku Major Business
Table 82. Teikoku Seiyaku Chronic Pain Topical Analgesics Product and Solutions
Table 83. Teikoku Seiyaku Chronic Pain Topical Analgesics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Teikoku Seiyaku Recent Developments and Future Plans
Table 85. The Pure Source Company Information, Head Office, and Major Competitors
Table 86. The Pure Source Major Business
Table 87. The Pure Source Chronic Pain Topical Analgesics Product and Solutions
Table 88. The Pure Source Chronic Pain Topical Analgesics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. The Pure Source Recent Developments and Future Plans
Table 90. Mercury Healthcare Company Information, Head Office, and Major Competitors
Table 91. Mercury Healthcare Major Business
Table 92. Mercury Healthcare Chronic Pain Topical Analgesics Product and Solutions
Table 93. Mercury Healthcare Chronic Pain Topical Analgesics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Mercury Healthcare Recent Developments and Future Plans
Table 95. Global Chronic Pain Topical Analgesics Revenue (USD Million) by Players (2018-2023)
Table 96. Global Chronic Pain Topical Analgesics Revenue Share by Players (2018-2023)
Table 97. Breakdown of Chronic Pain Topical Analgesics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Chronic Pain Topical Analgesics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 99. Head Office of Key Chronic Pain Topical Analgesics Players
Table 100. Chronic Pain Topical Analgesics Market: Company Product Type Footprint
Table 101. Chronic Pain Topical Analgesics Market: Company Product Application Footprint
Table 102. Chronic Pain Topical Analgesics New Market Entrants and Barriers to Market Entry
Table 103. Chronic Pain Topical Analgesics Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Chronic Pain Topical Analgesics Consumption Value (USD Million) by Type (2018-2023)
Table 105. Global Chronic Pain Topical Analgesics Consumption Value Share by Type (2018-2023)
Table 106. Global Chronic Pain Topical Analgesics Consumption Value Forecast by Type (2024-2029)
Table 107. Global Chronic Pain Topical Analgesics Consumption Value by Application (2018-2023)
Table 108. Global Chronic Pain Topical Analgesics Consumption Value Forecast by Application (2024-2029)
Table 109. North America Chronic Pain Topical Analgesics Consumption Value by Type (2018-2023) & (USD Million)
Table 110. North America Chronic Pain Topical Analgesics Consumption Value by Type (2024-2029) & (USD Million)
Table 111. North America Chronic Pain Topical Analgesics Consumption Value by Application (2018-2023) & (USD Million)
Table 112. North America Chronic Pain Topical Analgesics Consumption Value by Application (2024-2029) & (USD Million)
Table 113. North America Chronic Pain Topical Analgesics Consumption Value by Country (2018-2023) & (USD Million)
Table 114. North America Chronic Pain Topical Analgesics Consumption Value by Country (2024-2029) & (USD Million)
Table 115. Europe Chronic Pain Topical Analgesics Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Europe Chronic Pain Topical Analgesics Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Europe Chronic Pain Topical Analgesics Consumption Value by Application (2018-2023) & (USD Million)
Table 118. Europe Chronic Pain Topical Analgesics Consumption Value by Application (2024-2029) & (USD Million)
Table 119. Europe Chronic Pain Topical Analgesics Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Chronic Pain Topical Analgesics Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Chronic Pain Topical Analgesics Consumption Value by Type (2018-2023) & (USD Million)
Table 122. Asia-Pacific Chronic Pain Topical Analgesics Consumption Value by Type (2024-2029) & (USD Million)
Table 123. Asia-Pacific Chronic Pain Topical Analgesics Consumption Value by Application (2018-2023) & (USD Million)
Table 124. Asia-Pacific Chronic Pain Topical Analgesics Consumption Value by Application (2024-2029) & (USD Million)
Table 125. Asia-Pacific Chronic Pain Topical Analgesics Consumption Value by Region (2018-2023) & (USD Million)
Table 126. Asia-Pacific Chronic Pain Topical Analgesics Consumption Value by Region (2024-2029) & (USD Million)
Table 127. South America Chronic Pain Topical Analgesics Consumption Value by Type (2018-2023) & (USD Million)
Table 128. South America Chronic Pain Topical Analgesics Consumption Value by Type (2024-2029) & (USD Million)
Table 129. South America Chronic Pain Topical Analgesics Consumption Value by Application (2018-2023) & (USD Million)
Table 130. South America Chronic Pain Topical Analgesics Consumption Value by Application (2024-2029) & (USD Million)
Table 131. South America Chronic Pain Topical Analgesics Consumption Value by Country (2018-2023) & (USD Million)
Table 132. South America Chronic Pain Topical Analgesics Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Middle East & Africa Chronic Pain Topical Analgesics Consumption Value by Type (2018-2023) & (USD Million)
Table 134. Middle East & Africa Chronic Pain Topical Analgesics Consumption Value by Type (2024-2029) & (USD Million)
Table 135. Middle East & Africa Chronic Pain Topical Analgesics Consumption Value by Application (2018-2023) & (USD Million)
Table 136. Middle East & Africa Chronic Pain Topical Analgesics Consumption Value by Application (2024-2029) & (USD Million)
Table 137. Middle East & Africa Chronic Pain Topical Analgesics Consumption Value by Country (2018-2023) & (USD Million)
Table 138. Middle East & Africa Chronic Pain Topical Analgesics Consumption Value by Country (2024-2029) & (USD Million)
Table 139. Chronic Pain Topical Analgesics Raw Material
Table 140. Key Suppliers of Chronic Pain Topical Analgesics Raw Materials
List of Figures
Figure 1. Chronic Pain Topical Analgesics Picture
Figure 2. Global Chronic Pain Topical Analgesics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Chronic Pain Topical Analgesics Consumption Value Market Share by Type in 2022
Figure 4. Analgesic Creams
Figure 5. Analgesic Sprays
Figure 6. Pain Relief Patches
Figure 7. Global Chronic Pain Topical Analgesics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Chronic Pain Topical Analgesics Consumption Value Market Share by Application in 2022
Figure 9. Muscle Pain Picture
Figure 10. Arthritis Pain Picture
Figure 11. Global Chronic Pain Topical Analgesics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Chronic Pain Topical Analgesics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Chronic Pain Topical Analgesics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Chronic Pain Topical Analgesics Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Chronic Pain Topical Analgesics Consumption Value Market Share by Region in 2022
Figure 16. North America Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Chronic Pain Topical Analgesics Revenue Share by Players in 2022
Figure 22. Chronic Pain Topical Analgesics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Chronic Pain Topical Analgesics Market Share in 2022
Figure 24. Global Top 6 Players Chronic Pain Topical Analgesics Market Share in 2022
Figure 25. Global Chronic Pain Topical Analgesics Consumption Value Share by Type (2018-2023)
Figure 26. Global Chronic Pain Topical Analgesics Market Share Forecast by Type (2024-2029)
Figure 27. Global Chronic Pain Topical Analgesics Consumption Value Share by Application (2018-2023)
Figure 28. Global Chronic Pain Topical Analgesics Market Share Forecast by Application (2024-2029)
Figure 29. North America Chronic Pain Topical Analgesics Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Chronic Pain Topical Analgesics Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Chronic Pain Topical Analgesics Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Chronic Pain Topical Analgesics Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Chronic Pain Topical Analgesics Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Chronic Pain Topical Analgesics Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 39. France Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Chronic Pain Topical Analgesics Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Chronic Pain Topical Analgesics Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Chronic Pain Topical Analgesics Consumption Value Market Share by Region (2018-2029)
Figure 46. China Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 49. India Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Chronic Pain Topical Analgesics Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Chronic Pain Topical Analgesics Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Chronic Pain Topical Analgesics Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Chronic Pain Topical Analgesics Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Chronic Pain Topical Analgesics Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Chronic Pain Topical Analgesics Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 63. Chronic Pain Topical Analgesics Market Drivers
Figure 64. Chronic Pain Topical Analgesics Market Restraints
Figure 65. Chronic Pain Topical Analgesics Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Chronic Pain Topical Analgesics in 2022
Figure 68. Manufacturing Process Analysis of Chronic Pain Topical Analgesics
Figure 69. Chronic Pain Topical Analgesics Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source